Scientists grow mini human hearts from stem cells

These heart organoids could help doctors treat the most common birth defect — or maybe even prevent it.
Sign up for the Freethink Weekly newsletter!
A collection of our favorite stories straight to your inbox

Heart defects are the most common kind of birth defect in humans — nearly 1% of babies are born with some sort of problem with either the structure or function of their heart.

To treat or prevent these congenital heart defects, researchers need to be able to study developing human hearts — but they can’t ethically go into the womb and conduct tests on living fetuses.

They can study animal models, cell cultures, and donated fetal remains, but those options don’t allow them to see an actual human heart developing from day one.

A new option might, though.

Researchers at Michigan State have revealed, in a yet-to-be-peer-reviewed study, that they’ve grown tiny, functional models of human hearts, also known as “heart organoids,” from stem cells in the lab.

“Now we can have the best of both worlds, a precise human model to study these diseases — a tiny human heart — without using fetal material or violating ethical principles,” researcher Aitor Aguirre said in a press release. “This constitutes a great step forward.”

From Stem Cells to Heart Organoids

Researchers have already created organoids that mimic the function and structure of human lungs, kidneys, and brains, Recently, some have grown mini human heart pumps and even models of a human heart in cardiac arrest.

However, the MSU group’s heart organoids are unique: they contain all of the developing human heart’s primary cell types, as well as a functioning structure, including heart chambers and blood vessel-containing tissue.

After six days, the heart organoids began beating.

To create the mini hearts, the researchers started with donated adult skin or blood cells. They then genetically reprogrammed the cells back into their embryonic stem cell state, the way they were when they could still develop into any type of cell in the human body.

But the breakthrough was a new technique that coaxed the cells into developing into mini hearts. Six days in, the hearts began beating. By day 15, they were tiny spheres (about 0.4 inches in diameter) that contained all of the human heart’s primary cell types and structures.

This follows the timeline of actual fetal heart development — meaning the researchers were seeing the first couple weeks of the process in real-time.

The Beat Goes On

The MSU researchers are now studying defects in their heart organoids, in the hope of finding ways to treat or prevent congenital heart disease.

They’re also working to make their model more accurate.

“The organoids are small models of the fetal heart with representative functional and structural features,” researcher Yonatan Israeli said. “They are, however, not as perfect as a human heart yet. That is something we are working toward.”

Still, the organoids are already the most accurate lab-grown model of the developing human heart available, and according to MSU’s paper, released on the preprint server bioRXiv, the process for creating them is simple, efficient, and scalable.

The paper still needs to undergo peer-review, but if the research holds up, MSU’s heart organoids could give scientists an unprecedented look at the developing human heart — and a better understanding of all the things that can go wrong with it.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

Related
Revolutionary weight-loss drugs like Wegovy come with a catch
People taking GLP-1 agonists are losing too much muscle, but these drugs designed to prevent muscle loss could solve the problem.
What hybrid mouse/rat brains are showing us about the mind
Modified mice with hybrid brains that include rat neurons could one day lead to new breakthroughs in neuroscience.
AI can help predict whether a patient will respond to specific tuberculosis treatments
Instead of a one-size-fits-all treatment approach, AI could help personalize treatments for each patient to provide the best outcomes.
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but AI can help efficiently screen compounds that are lethal to dormant microbes.
Scientists are deep-freezing corals to repopulate the ocean
Healthy corals could disappear by the 2030s if climate change is not curbed, so scientists are deep freezing specimens.
Up Next
cancer and aging
Subscribe to Freethink for more great stories